HELLENIC DYNAMICS PLC Logo

HELLENIC DYNAMICS PLC

Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.

HELD | IL

Overview

Corporate Details

ISIN(s):
GB00BRXCFB77
LEI:
213800IM978BOB5QZA69
Country:
United Kingdom
Address:
21 ARLINGTON STREET, SW1A 1RN LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hellenic Dynamics PLC is a licensed cultivator and supplier of pharmaceutical-standard medical cannabis products, specializing in THC-dominant strains. Founded in 2018, the company operates a large-scale cultivation and production facility near Thessaloniki, Greece, with significant capacity for dried cannabis flowers and extracts. Its license allows for unlimited production, export, and THC content. The company's primary target is the European medical market, with an initial focus on Germany, where its first production phase was pre-sold to licensed distributors. Hellenic Dynamics aims to become a dominant European supplier by offering high-quality, competitively priced products and developing a proprietary, IP-protected library of THC genetics through research partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-12 18:45
Legal Proceedings Report
Further re: Winding-Up Petition
English 14.4 KB
2024-12-19 12:35
Legal Proceedings Report
Further re: Winding-Up Petition
English 11.7 KB
2024-11-26 11:00
Legal Proceedings Report
Winding-Up Petition
English 11.8 KB
2024-11-15 08:00
Capital/Financing Update
Update on €1 million loan
English 11.4 KB
2024-11-11 14:30
Regulatory News Service
Change of Registered Office
English 9.0 KB
2024-10-07 08:00
Capital/Financing Update
Update on receipt of €1 million loan
English 10.5 KB
2024-08-21 16:30
Capital/Financing Update
Update on receipt of €1 million loan
English 10.4 KB
2024-08-14 08:00
Legal Proceedings Report
Update on Petition and Related Party Transactions
English 14.6 KB
2024-08-01 14:10
Legal Proceedings Report
Winding-Up Petition
English 10.8 KB
2024-08-01 09:00
Delisting Announcement
Delay to the publication of accounts & Suspension
English 12.7 KB
2024-07-15 08:00
Share Issue/Capital Change
Settlement of Fees and Issue of Equity
English 15.4 KB
2024-07-08 11:30
Major Shareholding Notification
Holding(s) in Company
English 52.3 KB
2024-07-02 16:18
Major Shareholding Notification
Holding(s) in Company
English 52.7 KB
2024-07-02 11:45
Regulatory News Service
Facility, Cultivation and Market Update
English 31.4 KB
2024-06-25 08:00
Board/Management Information
Directorate Changes
English 13.9 KB

Automate Your Workflow. Get a real-time feed of all HELLENIC DYNAMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HELLENIC DYNAMICS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HELLENIC DYNAMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America APRE

Talk to a Data Expert

Have a question? We'll get back to you promptly.